Search clinical trials for: Contraindications to standard therapies

Total 477468 results

Eli Lilly and Company

Completed

Local Registration Trial in China Humalog Mix 50

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
International Partnership for Microbicides, Inc.

Completed

A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel

HIV Infections

Rwanda, South Africa, Tanzania
AstraZeneca

Completed

GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

Type 2 Diabetes

United States, Canada, France, Mexico
Abbott

Completed

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

HIV Infections

Spain, United Kingdom, United States, Canada, France, Poland, Argentina, Brazil, Italy, Puerto Rico
Julius-Maximilians University

Unknown

Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer

Cervical Cancer | Pancreatic Cancer | Colon Cancer | Malignant Melanoma

Germany
Nemours Children's Clinic
Washington University School of Medicine

Completed

Behavior Therapy for Families of Diabetic Adolescents

Type 1 Diabetes Mellitus

United States
Hamilton Health Sciences Corporation
The Physicians' Services Incorporated Foundation

Unknown

NExT ERA: National Expertise Based Trial of Elective Repair of Abdominal Aortic Aneurysms: A Pilot Study

Aortic Aneurysm, Abdominal

Canada
Sykehuset Telemark

Completed

Evaluation of 3-Dimensional Magnetic Imaging During Colonoscopy

Any Symptom Requiring Colonoscopy

Norway
Evolutec Group

Unknown

Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery

Ocular Inflammation

United States
Novartis

Completed

A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

Hypertension

Switzerland
UMC Utrecht
ZonMw: The Netherlands Organisation for Health Research and Development; Dr... and other collaborators

Completed

UDCA for Symptomatic Gallstone Disease

Cholecystolithiasis

Netherlands
Laboratoires Thea

Completed

Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis

Keratoconjunctivitis, Vernal
Laboratoires Thea

Completed

Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers

Eye Infections, Bacterial
Agency for Healthcare Research and Quality (AHRQ)

Completed

Care Management for Patients With Alzheimer Disease and Their Family Caregivers

Dementia | Alzheimer's Disease

United States
Portland VA Medical Center
GlaxoSmithKline; Schering-Plough

Completed

Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine

Major Depression
Connolly, Stuart, M.D.
Abbott Medical Devices

Completed

Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)

Ventricular Tachycardia

Canada
Vancouver General Hospital
Heart and Stroke Foundation of Canada; Vancouver Coastal Health Research Institute

Completed

Aminophylline in Bradyasystolic Cardiac Arrest

Cardiac Arrest

Canada
Abbott

Withdrawn

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

HIV Infection | Hepatitis C
Laboratoires Thea

Completed

Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome

Dry Eye Syndromes
Laboratoires Thea

Completed

Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers

Eye Infections, Bacterial
Abbott

Completed

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

HIV Infections

Spain, United Kingdom, United States, France, Australia, Germany, Singapore
Laboratoires Thea

Completed

Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis

Conjunctivitis, Bacterial
Abbott

Completed

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

HIV Infections

United States
Laboratoires Thea

Completed

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

Eye Infections, Bacterial

France
Tufts University
National Institutes of Health (NIH)

Completed

Effect of Calcium and Vitamin D on Bone Loss From the Hip

Osteoporosis

United States
Medical University of Vienna

Completed

Vienna Absolute Trial: Balloon Angioplasty Versus Stenting in the Superficial Femoral Artery

Atherosclerosis

Austria
National Center for Complementary and Integrative...

Completed

Valerian to Improve Sleep in Patients With Parkinson's Disease

Parkinson's Disease | Insomnia

United States
Laboratoires Thea

Completed

Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma

Trachoma
National Center for Complementary and Integrative...

Completed

Effects of Ginseng and Ginkgo on Drug Disposition in Man

Healthy

United States
Gachon University Gil Medical Center

Completed

Safety and Effects of Ramipril Combined With Candesartan

Hypertension
University Hospital Freiburg
Almased Wellness GmbH

Completed

Changes in Body Composition and Metabolic Risk Parameters by Life Style Intervention.

Obesity | Metabolic Syndrome

Germany
Laboratoires Thea

Completed

Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers

Eye Infections, Bacterial
Laboratoires Thea

Completed

Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers

Eye Infections, Bacterial
Medical University of Vienna

Unknown

Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation

Liver Transplantation | Osteoporosis

Austria
Abarbanel Mental Health Center

Completed

Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

Israel
National Center for Complementary and Integrative...

Completed

High Intensity Light Therapy in Alzheimer's Disease

Dementia | Alzheimer's Disease

United States
Tawam Hospital

Unknown

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

B-Cell Chronic Lymphocytic Leukemia
Eli Lilly and Company
Boehringer Ingelheim

Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

Stress Urinary Incontinence

United States
Charite University, Berlin, Germany

Unknown

HAI Via Interventionally Implanted Port Catheter Systems

Liver Neoplasms | Hepatocellular Carcinoma | Colorectal Cancer | Bile Duct Cancer | Gallbladder Cancer

Germany
Pfizer
PPD

Completed

A First In Human Study Of PF-00184562 In Healthy Volunteers

Schizophrenia

United States
Pfizer

Completed

CP-481,715 Nickel Allergy Study.

Dermatitis, Allergic Contact

United States, Denmark
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Azienda Ospedaliera San Giovanni Battista

Terminated

Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Italy
Pfizer

Completed

Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction

Impotence

United States
Pfizer

Completed

Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction

Impotence
Eli Lilly and Company

Completed

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Bipolar Disorder

Spain
Eli Lilly and Company

Completed

Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

Germany, United States, Belgium, France, Norway, Portugal, Spain, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

United States
A.O. Ospedale Papa Giovanni XXIII

Completed

BASTA Study on STI in HIV Infected Patients

HIV Infection

Italy

Search clinical trials for: Contraindications to standard therapies

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations